Filing Details

Home > Insider Trading > Latest 13D and 13G Filings > 13D Filing (0001193125-19-233227)

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

WITH

Sole Voting Power

13,047,754

Shared Voting Power

0

Sole Dispositive Power

13,047,754

Shared Dispositive Power

0

Accession Number:: 0001193125-19-233227
Form Type:: 13D Filing
Publication Date:: 2019-08-29 10:09:07

Filed By:: Maruho Co., Ltd.
Company:: Biofrontera Ag
Filing Date:: 2019-08-29
SEC Url:: 13D Filing

Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name	Sole Voting Power	Shared Voting Power	Sole Dispositive Power	Shared Dispositive Power	Aggregate Amount Owned Power	Percent of Class
Maruho Co., Ltd	13,047,754	0	13,047,754	0	13,047,754
Maruho Deutschland GmbH	13,047,754	0	13,047,754	0	13,047,754

Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C.

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 1)

BIOFRONTERA AG

(Name of Issuer)

Ordinary Shares, with no par value, 1.00 nominal value per share

(Title of Class of Securities)

09075G105**

(CUSIP Number)

Maruho Deutschland GmbH

Hemmelrather Weg 201, Haus 2

51377 Leverkusen, Germany

Telephone: +49(0)214-892201-0

Copies to:

John J. Harrington

Baker & Hostetler LLP

127 Public Square, Suite 2000

Cleveland, Ohio 44114-1214

Telephone: (216) 621-0200

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

August 28, 2019

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

*	The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

**	The Ordinary Shares have no CUSIP number. The CUSIP number for the ADSs, each representing two Ordinary Shares, is 09075G105.

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (Act), or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 09075G105		SCHEDULE 13D


1		NAME OF REPORTING PERSON Maruho Co., Ltd.
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐
3		SEC USE ONLY
4		SOURCE OF FUNDS (SEE INSTRUCTIONS) WC
5		CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) ☐
6		CITIZENSHIP OR PLACE OF ORGANIZATION Japan

(1)	Based upon 44,757,015 shares outstanding as reported in the Issuers Form 6-K filed on July 31, 2019.


CUSIP No. 09075G105		SCHEDULE 13D


1		NAME OF REPORTING PERSON Maruho Deutschland GmbH
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) ☐ (b) ☐
3		SEC USE ONLY
4		SOURCE OF FUNDS (SEE INSTRUCTIONS) AF
5		CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) ☐
6		CITIZENSHIP OR PLACE OF ORGANIZATION Germany

(1)	Based upon 44,757,015 shares outstanding as reported in the Issuers Form 6-K filed on July 31, 2019.


CUSIP No. 09075G105		SCHEDULE 13D

SCHEDULE 13D

This Amendment No. 1 (Amendment No. 1) amends and supplements the Schedule 13D (the Initial Schedule 13D and together with Amendment No. 1, the Schedule 13D) filed with the Securities and Exchange Commission on July 24, 2019 by Maruho Co., Ltd. (Maruho Japan) and its wholly-owned subsidiary, Maruho Deutschland GmbH (Maruho Germany and together with Maruho Japan, the Reporting Persons) with respect to the Ordinary Shares, with no par value,1.00 nominal value per share (the Shares), of Biofrontera AG (Biofrontera or the Issuer). Capitalized terms used herein and not otherwise defined in this Amendment No. 1 shall have the meanings set forth in the Initial Schedule 13D. This Amendment No. 1 amends Items 3 and 5 to the extent set forth below.

Item 3. Source or Amount of Funds or Other Consideration.

Item 3 of the Schedule 13D is hereby supplemented as follows;

Maruho Japan contributed funds to Maruho Germany in order to finance the acquisitions of Shares disclosed in Item 5(c) of this Amendment No. 1. The source of these funds was cash on hand and working capital of Maruho Japan.

Item 5. Interest in Securities of the Issuer.

Item 5 of the Schedule 13D is hereby amended and restated in its entirety to read as follows:

(a) (b) The Reporting Persons had, as of August 28, 2019 after giving effect to the acquisition of additional Shares specified under (c) below, sole power to vote or to direct the vote and sole power to dispose or to direct the disposition of 13,047,754 Shares, representing 29.15% of the 44,757,015 outstanding Shares as reported in the Issuers Form 6-K filed on July 31, 2019. Maruho Japan is the indirect beneficial owner of such Shares and its wholly-owned subsidiary Maruho Germany is the direct beneficial owner of such Shares. Mr. Kenichi Owada and Mr. Seiichi Takada, Managing Directors of Maruho Germany, each have sole voting and dispositive power over a single Share.

(c) Information with respect to all transactions in the Shares outside the Acquisition Offer since the filing of the Initial Schedule 13D by the Reporting Persons is set forth on Schedule 2 hereto.

(d) (e) Not applicable.

SIGNATURE

After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete, and correct.


Dated: August 28, 2019	MARUHO CO., LTD.

	By:	/s/ Koichi Takagi
	Name:	Koichi Takagi
	Title:	President and CEO

	MARUHO DEUTSCHLAND GMBH

	By:	/s/ Junichi Hamada
	Name:	Junichi Hamada
	Title:	Managing Director

SCHEDULE 2

The following table sets forth all transactions in the Shares effected outside the Acquisition Offer since the filing of the Initial Schedule 13D. All such transactions were effected in the EU regulated and in the open market (primarily on XETRA Frankfurt/Main) and the price per Share excludes commissions.


Shares Purchased	Price per Share ()	Transaction Date
701	6.59	8/28/19
964	6.59	8/28/19
60	6.59	8/28/19
8029	6.59	8/28/19
13111	6.59	8/28/19
10000	6.59	8/28/19
76	6.585	8/28/19
10000	6.59	8/28/19
5000	6.59	8/28/19
77	6.585	8/28/19
1000	6.58	8/28/19
176	6.58	8/28/19
130	6.58	8/28/19
10000	6.59	8/28/19
10000	6.59	8/28/19
5000	6.59	8/28/19
283	6.59	8/28/19
5147	6.59	8/28/19
1113	6.59	8/28/19
8000	6.59	8/28/19
8000	6.59	8/28/19
5000	6.59	8/28/19
694	6.58	8/28/19
140	6.58	8/28/19
860	6.58	8/28/19
286	6.58	8/28/19
45	6.585	8/28/19
2	6.58	8/28/19
148	6.585	8/28/19
562	6.58	8/28/19
150	6.58	8/28/19
136	6.58	8/28/19
136	6.58	8/28/19
273	6.58	8/28/19
455	6.58	8/28/19
1	6.58	8/28/19
1	6.58	8/28/19
2	6.58	8/28/19
5	6.58	8/28/19


9	6.58	8/28/19
19	6.58	8/28/19
37	6.58	8/28/19
74	6.58	8/28/19
36	6.58	8/28/19
316	6.58	8/28/19
500	6.58	8/28/19
243	6.58	8/28/19
757	6.58	8/28/19
500	6.59	8/28/19
1500	6.59	8/28/19
27	6.54	8/27/19
105	6.54	8/27/19
152	6.54	8/27/19
268	6.54	8/27/19
97	6.54	8/27/19
86	6.54	8/27/19
49	6.54	8/27/19
332	6.54	8/27/19
500	6.54	8/27/19
535	6.54	8/27/19
500	6.54	8/27/19
367	6.54	8/27/19
144	6.54	8/27/19
122	6.54	8/27/19
450	6.54	8/27/19
456	6.57	8/27/19
50	6.54	8/27/19
500	6.54	8/27/19
559	6.56	8/27/19
3805	6.59	8/27/19
3892	6.59	8/27/19
1108	6.56	8/27/19
6869	6.59	8/27/19
131	6.575	8/27/19
634	6.59	8/27/19
366	6.56	8/27/19
5355	6.59	8/27/19
292	6.575	8/27/19
1276	6.56	8/27/19
5000	6.59	8/27/19
77	6.575	8/27/19
136	6.58	8/27/19
275	6.58	8/27/19
71	6.58	8/27/19


432	6.58	8/27/19
563	6.58	8/27/19
95	6.56	8/27/19
428	6.56	8/27/19
1847	6.58	8/27/19
7898	6.58	8/27/19
255	6.575	8/27/19
2415	6.58	8/27/19
2585	6.58	8/27/19
2000	6.58	8/27/19
500	6.56	8/27/19
4482	6.59	8/27/19
3	6.59	8/27/19
14	6.59	8/27/19
327	6.59	8/27/19
33	6.59	8/27/19
344	6.59	8/27/19
976	6.59	8/27/19
78	6.59	8/27/19
104	6.59	8/27/19
79	6.59	8/27/19
45	6.59	8/27/19
39	6.59	8/27/19
178	6.59	8/27/19
95	6.59	8/27/19
86	6.59	8/27/19
102	6.59	8/27/19
98	6.59	8/27/19
11	6.59	8/27/19
794	6.59	8/27/19
372	6.59	8/27/19
692	6.59	8/27/19
33	6.59	8/27/19
2	6.58	8/26/19
13	6.58	8/26/19
1000	6.58	8/26/19
145	6.58	8/20/19
355	6.58	8/20/19
500	6.58	8/19/19
194	6.58	8/19/19
306	6.58	8/19/19
500	6.58	8/19/19
35	6.54	8/19/19
677	6.54	8/19/19
843	6.52	8/16/19


29	6.54	8/16/19
32	6.54	8/16/19
32	6.53	8/16/19
32	6.54	8/16/19
2	6.5	8/16/19
32	6.53	8/16/19
998	6.5	8/16/19
1,000	6.5	8/16/19
865	6.5	8/16/19
981	6.5	8/16/19
1684	6.5	8/16/19
85	6.5	8/16/19
61	6.5	8/16/19
4939	6.5	8/16/19
500	6.47	8/16/19
872	6.5	8/16/19
126	6.52	8/16/19
125	6.52	8/16/19
125	6.52	8/16/19
3918	6.5	8/16/19
200	6.47	8/16/19
800	6.47	8/16/19
2500	6.5	8/16/19
164	6.485	8/16/19
163	6.485	8/16/19
163	6.485	8/16/19
69	6.47	8/16/19
931	6.47	8/16/19
500	6.47	8/16/19
426	6.53	8/16/19
426	6.53	8/16/19
1722	6.5	8/16/19
64	6.53	8/16/19
107	6.53	8/16/19
89	6.53	8/16/19
107	6.53	8/16/19
89	6.53	8/16/19
107	6.53	8/16/19
89	6.53	8/16/19
107	6.53	8/16/19
89	6.53	8/16/19
89	6.53	8/16/19
107	6.53	8/16/19
107	6.53	8/16/19
3278	6.5	8/16/19


106	6.555	8/16/19
820	6.52	8/16/19
107	6.555	8/16/19
2808	6.52	8/16/19
1944	6.52	8/16/19
1385	6.545	8/16/19
2674	6.52	8/16/19
382	6.52	8/16/19
4236	6.52	8/16/19
382	6.52	8/16/19
382	6.52	8/16/19
2617	6.52	8/16/19
382	6.52	8/16/19
1	6.52	8/16/19
381	6.52	8/16/19
743	6.52	8/16/19
382	6.52	8/16/19
89	6.545	8/16/19
107	6.545	8/16/19
1266	6.545	8/16/19
904	6.52	8/16/19
9836	6.52	8/16/19
1000	6.53	8/16/19
2000	6.53	8/16/19
620	6.52	8/16/19
380	6.52	8/16/19
923	6.54	8/16/19
2843	6.52	8/16/19
25	6.53	8/16/19
1	6.52	8/16/19
1229	6.53	8/16/19
416	6.52	8/16/19
32	6.52	8/16/19
1200	6.52	8/16/19
1283	6.545	8/16/19
1000	6.52	8/16/19
10000	6.52	8/16/19
5000	6.52	8/16/19
5000	6.52	8/16/19
1000	6.52	8/16/19
3013	6.52	8/16/19
1340	6.55	8/16/19
500	6.55	8/16/19
500	6.55	8/16/19
387	6.52	8/16/19


1314	6.55	8/16/19
686	6.55	8/16/19
1100	6.52	8/16/19
500	6.52	8/16/19
177	6.54	8/15/19
25	6.54	8/15/19
798	6.54	8/15/19
340	6.54	8/15/19
104	6.525	8/15/19
156	6.525	8/15/19
1075	6.54	8/15/19
38	6.54	8/15/19
37	6.54	8/15/19
37	6.54	8/15/19
194	6.54	8/15/19
24	6.53	8/15/19
518	6.53	8/15/19
2000	6.53	8/15/19
1791	6.52	8/15/19
120	6.54	8/15/19
209	6.52	8/15/19
166	6.55	8/15/19
191	6.545	8/15/19
2019	6.57	8/15/19
376	6.56	8/15/19
252	6.55	8/15/19
15	6.55	8/15/19
15	6.55	8/15/19
709	6.55	8/15/19
1000	6.55	8/15/19
1000	6.55	8/15/19
110	6.53	8/15/19
340	6.53	8/15/19
50	6.53	8/15/19
500	6.53	8/15/19
1000	6.53	8/15/19
1000	6.53	8/15/19
1000	6.53	8/15/19
1000	6.53	8/15/19
90	6.53	8/15/19
346	6.53	8/15/19
564	6.53	8/15/19
1000	6.53	8/15/19
455	6.53	8/15/19
297	6.53	8/15/19


309	6.53	8/15/19
1640	6.53	8/15/19
507	6.53	8/15/19
602	6.53	8/15/19
105	6.53	8/15/19
85	6.53	8/15/19
4600	6.53	8/15/19
345	6.5	8/15/19
244	6.5	8/15/19
1820	6.53	8/15/19
405	6.53	8/15/19
352	6.53	8/15/19
423	6.53	8/15/19
226	6.53	8/15/19
700	6.53	8/15/19
409	6.53	8/15/19
342	6.53	8/15/19
323	6.53	8/15/19
314	6.53	8/15/19
500	6.53	8/15/19
742	6.53	8/15/19
1444	6.53	8/15/19
13	6.5	8/15/19
954	6.5	8/15/19
33	6.5	8/15/19
221	6.5	8/15/19
179	6.5	8/15/19
100	6.5	8/15/19
210	6.53	8/15/19
290	6.53	8/15/19
120	6.53	8/15/19
559	6.53	8/15/19
1322	6.53	8/15/19
3000	6.55	8/15/19
271	6.53	8/15/19
335	6.53	8/15/19
320	6.53	8/15/19
280	6.53	8/15/19
293	6.53	8/15/19
257	6.53	8/15/19
378	6.53	8/15/19
365	6.53	8/15/19
1649	6.55	8/15/19
351	6.55	8/15/19
336	6.55	8/15/19


361	6.55	8/15/19
397	6.55	8/15/19
369	6.56	8/15/19
239	6.56	8/15/19
319	6.56	8/15/19
400	6.56	8/15/19
497	6.56	8/15/19
676	6.56	8/15/19
1028	6.555	8/15/19
10	6.55	8/15/19
1028	6.555	8/15/19
396	6.55	8/15/19
1026	6.57	8/15/19
1000	6.55	8/15/19
28	6.57	8/15/19
1037	6.57	8/15/19
855	6.56	8/15/19
1600	6.57	8/15/19
1027	6.56	8/15/19
796	6.57	8/15/19
500	6.55	8/15/19
273	6.58	8/15/19
672	6.58	8/15/19
28	6.58	8/15/19
22	6.58	8/15/19
205	6.58	8/15/19
1300	6.58	8/15/19
32	6.58	8/15/19
355	6.58	8/15/19
500	6.58	8/15/19
120	6.58	8/15/19
250	6.58	8/15/19
243	6.58	8/15/19
283	6.59	8/14/19
717	6.57	8/14/19
306	6.57	8/14/19
4694	6.53	8/14/19
950	6.58	8/14/19
50	6.55	8/14/19
106	6.57	8/14/19
459	6.57	8/14/19
800	6.55	8/14/19
88	6.55	8/14/19
10000	6.55	8/14/19
7547	6.55	8/14/19


2450	6.55	8/14/19
50	6.58	8/14/19
500	6.58	8/14/19
1536	6.58	8/14/19
2000	6.575	8/14/19
2464	6.58	8/14/19
115	6.58	8/14/19
244	6.58	8/14/19
641	6.58	8/14/19
39	6.59	8/13/19
22	6.59	8/13/19
69	6.59	8/13/19
211	6.59	8/13/19
99	6.59	8/13/19
60	6.59	8/13/19
150	6.59	8/13/19
350	6.59	8/13/19
366	6.59	8/13/19
831	6.58	8/13/19
500	6.57	8/13/19
325	6.59	8/13/19
220	6.53	8/13/19
111	6.59	8/13/19
1183	6.58	8/13/19
5	6.55	8/13/19
959	6.55	8/13/19
2000	6.58	8/13/19
500	6.58	8/13/19
9	6.58	8/12/19
7	6.55	8/12/19
7	6.55	8/12/19
377	6.55	8/12/19
830	6.58	8/12/19
286	6.565	8/12/19
1500	6.55	8/12/19
2098	6.55	8/12/19
5000	6.5	8/12/19
3000	6.55	8/12/19
286	6.565	8/12/19
158	6.58	8/12/19
475	6.58	8/12/19
289	6.57	8/12/19
287	6.54	8/12/19
200	6.55	8/12/19
358	6.53	8/12/19


215	6.545	8/12/19
743	6.56	8/12/19
23275	6.56	8/12/19
8034	6.56	8/12/19
1966	6.56	8/12/19
50	6.55	8/12/19
450	6.55	8/12/19
119	6.55	8/12/19
381	6.55	8/12/19
50	6.55	8/12/19
450	6.55	8/12/19
151	6.55	8/12/19
349	6.55	8/12/19
55	6.55	8/12/19
495	6.55	8/12/19
450	6.55	8/12/19
5000	6.55	8/12/19
5000	6.55	8/12/19
264	6.54	8/12/19
336	6.54	8/12/19
135	6.54	8/12/19
165	6.54	8/12/19
165	6.54	8/12/19
267	6.54	8/12/19
168	6.54	8/12/19
237	6.54	8/12/19
318	6.54	8/12/19
10	6.54	8/12/19
87	6.54	8/12/19
261	6.54	8/12/19
280	6.54	8/12/19
307	6.53	8/12/19
58	6.55	8/12/19
2386	6.55	8/12/19
556	6.53	8/12/19
5000	6.56	8/12/19
600	6.58	8/12/19
30	6.58	8/12/19
120	6.58	8/12/19
120	6.58	8/12/19
200	6.58	8/12/19
130	6.58	8/12/19
200	6.58	8/12/19
140	6.58	8/12/19
100	6.58	8/12/19


130	6.58	8/12/19
120	6.58	8/12/19
110	6.58	8/12/19
200	6.58	8/12/19
200	6.58	8/12/19
200	6.58	8/12/19
200	6.58	8/12/19
200	6.58	8/12/19
11	6.58	8/12/19
389	6.58	8/12/19
200	6.58	8/12/19
32	6.58	8/12/19
168	6.58	8/12/19
200	6.58	8/12/19
89	6.59	8/8/19
293	6.59	8/8/19
184	6.59	8/8/19
434	6.59	8/8/19
268	6.59	8/8/19
293	6.59	8/8/19
377	6.59	8/8/19
275	6.59	8/8/19
616	6.59	8/8/19
586	6.59	8/8/19
1004	6.59	8/8/19
696	6.59	8/8/19
21	6.59	8/8/19
293	6.59	8/8/19
390	6.59	8/8/19
160	6.59	8/8/19
168	6.59	8/8/19
72	6.59	8/8/19
44	6.59	8/8/19
156	6.59	8/8/19
107	6.59	8/7/19
233	6.59	8/7/19
77	6.565	8/7/19
100	6.565	8/7/19
110	6.565	8/7/19
2149	6.59	8/7/19
78	6.56	8/7/19
1423	6.59	8/7/19
306	6.59	8/7/19
349	6.59	8/7/19
1105	6.58	8/7/19


2000	6.54	8/7/19
963	6.56	8/7/19
500	6.45	8/7/19
500	6.45	8/7/19